ProMIS Neurosciences raises $3M from PIPE; total proceeds of ~$12M including warrant exercises

ProMIS Neurosciences Inc.

Raised ~$3M gross via PIPE sale of warrants at $0.1875/share with exercise price $1.25; closing July 29, 2025.
Combined with proceeds from existing warrant exercises, total gross proceeds ~$12M.
Warrants immediately exercisable, expire in 5 years; subject to 4.99%/9.99% ownership blocker.
Proceeds to fund clinical development of lead candidate PMN310 for Alzheimer's and other neurodegenerative diseases.
Participation from existing institutional investors including Ally Bridge Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.